WASHINGTON (AP) — Federal health advisers on Wednesday narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig's disease, a potential setback for patient groups who have lobbied for the medication's approval.
Heavyweights Pfizer, Novartis, and Lilly, and the smaller biopharma, Incyte had TV ads during the Oscars on Sunday. These ads weren’t cheap. Thirty second spots ran anywhere from $1.7 - $2.2 million.
Roche said Wednesday that an experimental cancer immunotherapy directed against a target called TIGIT failed to slow the progression of a less common but aggressive type of lung cancer.
Anyone 50 years and older could soon be eligible for a second booster dose of the Moderna or Pfizer-BioNtech COVID-19 vaccine. The FDA is expected to authorize the additional booster shots without holding a meeting of its independent vaccine advisors.